Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke

Published: November 02, 2017

Science News on light gray background
  • While symptomatic intracranial hemorrhage (sICH) is uncommon, it is the most feared complication of intravenous thrombolytic therapy in acute ischemic stroke.
  • Treatment of sICH is currently based on expert opinion or small observational studies.
  • This scientific statement provides an overview of sICH, discussing pathophysiology and treatment options.